自身免疫反应和治疗复发性生物假体肺功能障碍
Francis E Ezekwueme1, Bryan H Goldstein2, Carley Bright2
1Heart Institute, UPMC Children's Hospital of Pittsburgh and UPMC Heart and Vascular Institute, Pittsburgh, Pennsylvania, USA.
JACC. Case reports
|September 26, 2025
概括
一个罕见的生物假体肺衰竭病例是由对的过敏反应引起的. 过敏测试发现了金属,用免疫抑制和抗组胺药物治疗改善了门功能.
科学领域:
- 心脏病学 心脏病学
- 过敏和免疫学 过敏和免疫学
- 生物材料科学 生物材料科学
背景情况:
- 生物假肢失效是心脏病患者的主要并发症,通常是由于叶片变性.
- 常见的原因包括内心炎,化和血栓形成.
- 门故障的罕见病因需要彻底调查.
研究的目的:
- 报告一种罕见的生物假体肺失效病例.
- 调查故障的原因,特别是探索非传染性和非退行性机制.
- 描述诊断过程和成功管理这一独特的呈现.
主要方法:
- 临床病例介绍和详细的病史.
- 诊断工作,包括排除感染原因.
- 专门的过敏测试 (皮肤测试) 以确定潜在的触发因素.
- 用免疫抑制疗法和抗组胺剂进行治疗.
主要成果:
- 生物假体肺失效是由于对合金的过敏反应造成的,这是门的一个组成部分.
- 皮肤过敏测试证实了过敏.
- 用免疫抑制和抗组胺药物治疗导致症状缓解和改善膜功能.
结论:
- 对生物假体门中的金属部件的过敏反应可能导致设备故障.
- 过敏是一种罕见但重要的生物假体门功能障碍的原因.
- 诊断需要一个高的怀疑指数和特定的过敏测试,管理涉及免疫抑制和抗组胺药物.
相关概念视频
Mitral Stenosis III: Medical Management
247
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
247
Endocarditis III: Medical Management
213
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
213
Aortic Regurgitation III: Medical Management
397
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
397
Mitral Regurgitation III: Medical Management
284
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
284
Rheumatic Heart Disease III: Medical Management
289
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
289
Mitral Stenosis IV: Nursing Management
247
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
247


